Skip to content
Home/Companies/HealthTech/BioCorteX
BioCorteX

BioCorteX

HealthTech·United Kingdom·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns BioCorteX?

BioCorteX is a British HealthTech company, currently owned by Sofinnova Partners since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Digital Medicine I · 2022 · VC

Key facts

HQUnited Kingdom
SectorHealthTech
Websitebiocortex.com

More from Sofinnova Digital Medicine I

Other portfolio companies in the same fund.

Ingenix
Active
AI/MLPoland· 2026
Excelsior Sciences
Active
HealthTechUS· 2025
Latent Labs
Latent Labs
Active
HealthTechUK· 2025
Bioptimus
Bioptimus
Active
BiotechFrance· 2024
Cure51
Cure51
Active
HealthTechFrance· 2024
Kiro
Kiro
Active
HealthTechFrance· 2023

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns BioCorteX?

BioCorteX is currently owned by Sofinnova Partners, through Sofinnova Digital Medicine I, since 2022.

When did Sofinnova Partners acquire BioCorteX?

Sofinnova Partners acquired BioCorteX in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue